Natco Pharma Q1 net profit up 93 percent to Rs 181 crore
New Delhi: Drug firm Natco Pharma reported a 93.27 percent rise in its consolidated net profit to Rs 181.1 crore for the quarter ended June 30 mainly on account of robust sales.
The company had posted a net profit of Rs 93.7 crore for the corresponding period of the previous fiscal, Natco Pharma said in a BSE filing.
Consolidated total revenue of the company stood at Rs 574.5 crore for the quarter under consideration. It was Rs 448.7 crore in the corresponding period of the previous fiscal.
The company's board of directors have approved an interim dividend of Rs 1.50 per equity share of Rs 2 each, Natco Pharma said.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd